HEALTH

BOSTON — Men with prostate cancer are at a higher risk of developing diabetes or diabetes risk factors if they receive a therapy designed to block the production of testosterone, a new study has suggested.

IRVINE, Calif. — ChromaDex on Monday announced it will launch a supplement line in GNC called BluScience in July.

"We are extremely excited about the BluScience launch with GNC, given the innovative and novel ingredient pTeroPure, which is the foundation for the BluScience line," GNC VP merchandising Ted Deitrick said.

SILVER SPRING, Md. — The Food and Drug Administration has approved changes to the labels of several drugs made by Merck, the agency said Friday.

Merck’s Label Standardization Project includes the revision of 34 container labels for 16 drugs, all orally administered pills. These include the cardiovascular drugs Cozaar (losartan) and Hyzaar (losartan and hydrochlorothiazide), the diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin and metformin), the allergy and asthma drug Singulair (montelukast), the HIV drug Isentress (raltegravir) and others.

MT. KISCO, N.Y. — Increasingly, social media is leveling the playing field for small- and mid-sized brand marketers, opening new, more affordable and more effective avenues to communicate with consumers versus such traditional media as TV and radio. And new research suggests the balance of power already may be tipping in favor of social marketing, particularly in certain categories and definitely among certain consumers.

NEW YORK and WATERTOWN, Mass. — The Juvenile Diabetes Research Foundation and Selecta Biosciences have established a research collaboration to develop vaccines for Type 1 diabetes, also known as juvenile diabetes.

Through the collaboration, JDRF will provide "milestone-based financial support and expertise" to Selecta, which ultimately would apply its vaccine technology to create a vaccine that would halt or prevent the autoimmune response that causes Type 1 diabetes.

ST. PAUL, Minn. — 3M’s Nexcare bandages, in partnership with the American Red Cross and model Niki Taylor, on Thursday announced the third annual Nexcare Give program on World Blood Donor Day on June 14.

INDIANAPOLIS — Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

NEW YORK — The National Advertising Division of the Council of Better Business Bureaus earlier this week recommended that New Nordic US modify or discontinue a wide range of advertising claims for the company’s Mulberry Zuccarin dietary supplement product, including claims made in testimonials.